Literature DB >> 35693398

The impact of associating liver partition and portal vein ligation for staged hepatectomy (ALPPS) on liver tumors with unusual indications.

Kensuke Yamamura1, Toru Beppu1, Tatsunori Miyata2, Shinichi Akahoshi1, Takatoshi Ishiko1.   

Abstract

Entities:  

Year:  2022        PMID： 35693398      PMCID： PMC9186199          DOI： 10.21037/hbsn-2022-11

Source DB:  PubMed          Journal:  Hepatobiliary Surg Nutr        ISSN： 2304-3881            Impact factor:   8.265


× No keyword cloud information.
  20 in total

1.  Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses.

Authors:  Andreas Stang
Journal:  Eur J Epidemiol       Date:  2010-07-22       Impact factor: 8.082

2.  Drop of Total Liver Function in the Interstages of the New Associating Liver Partition and Portal Vein Ligation for Staged Hepatectomy Technique: Analysis of the "Auxiliary Liver" by HIDA Scintigraphy.

Authors:  Stéphanie Truant; Clio Baillet; Anne Claire Deshorgue; Emmanuelle Leteurtre; Mohamed Hebbar; Olivier Ernst; Damien Huglo; François-René Pruvot
Journal:  Ann Surg       Date:  2016-03       Impact factor: 12.969

3.  Tumor progression in two-stage liver resections-is the shorter inter-stage period in associated liver partition and portal vein ligation for staged hepatectomy (ALPPS) of benefit to the patient?

Authors:  Ernesto Sparrelid; Thomas M van Gulik
Journal:  Hepatobiliary Surg Nutr       Date:  2019-06       Impact factor: 7.293

4.  Associating liver partition and portal vein ligation for staged hepatectomy (ALPPS): impact of the inter-stages course on morbi-mortality and implications for management.

Authors:  S Truant; O Scatton; S Dokmak; J-M Regimbeau; V Lucidi; A Laurent; R Gauzolino; C Castro Benitez; A Pequignot; V Donckier; C Lim; M-L Blanleuil; R Brustia; Y-P Le Treut; O Soubrane; D Azoulay; O Farges; R Adam; F-R Pruvot
Journal:  Eur J Surg Oncol       Date:  2015-01-17       Impact factor: 4.424

5.  The many faces of ALPPS: surgical indications and techniques among surgeons collaborating in the international registry.

Authors:  Suzana Buac; Erik Schadde; Andreas A Schnitzbauer; Kelly Vogt; Roberto Hernandez-Alejandro
Journal:  HPB (Oxford)       Date:  2016-03-10       Impact factor: 3.647

Review 6.  Conversion Surgery for Hepatocellular Carcinoma Following Molecular Therapy.

Authors:  Kensuke Yamamura; Toru Beppu; Tatsunori Miyata; Hirohisa Okabe; Hidetoshi Nitta; Katsunori Imai; Hiromitsu Hayashi; Shinichi Akahoshi
Journal:  Anticancer Res       Date:  2022-01       Impact factor: 2.480

7.  Chemotherapy and targeted therapy for patients with initially unresectable colorectal liver metastases, focusing on conversion hepatectomy and long-term survival.

Authors:  Toru Beppu; Yuji Miyamoto; Yasuo Sakamoto; Katsunori Imai; Hidetoshi Nitta; Hiromitsu Hayashi; Akira Chikamoto; Masayuki Watanabe; Takatoshi Ishiko; Hideo Baba
Journal:  Ann Surg Oncol       Date:  2014-02-26       Impact factor: 5.344

Review 8.  Liver transplantation for neuroendocrine tumour liver metastases.

Authors:  Sheung Tat Fan; Yves Patrice Le Treut; Vincenzo Mazzaferro; Andrew K Burroughs; Michael Olausson; Stefan Breitenstein; Andrea Frilling
Journal:  HPB (Oxford)       Date:  2014-07-03       Impact factor: 3.647

9.  Scandinavian multicenter study on the safety and feasibility of the associating liver partition and portal vein ligation for staged hepatectomy procedure.

Authors:  Bård I Røsok; Bergthor Björnsson; Ernesto Sparrelid; Kristina Hasselgren; Ewa Pomianowska; Thomas Gasslander; Bjørn Atle Bjørnbeth; Bengt Isaksson; Per Sandström
Journal:  Surgery       Date:  2015-11-19       Impact factor: 3.982

Review 10.  Evolving Paradigms in the Systemic Treatment of Advanced Gallbladder Cancer: Updates in Year 2022.

Authors:  Zishuo Ian Hu; Kian-Huat Lim
Journal:  Cancers (Basel)       Date:  2022-02-28       Impact factor: 6.639
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.